<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Structural studies of HCV polymerase (genotype 1b) in complex with allosteric inhibitors</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability  status="unknown">
					<licence/>
				</availability>
				<date type="published" when="2004-11-25">25 November 2004 to: 26 November 2004</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Joanna</forename><surname>Timmins</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Biochemistry</orgName>
								<orgName type="institution">IRBM P.Angeletti</orgName>
								<address>
									<postCode>I-00040</postCode>
									<settlement>Pomezia Rome</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Raimond</forename><surname>Ravelli</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Biochemistry</orgName>
								<orgName type="institution">IRBM P.Angeletti</orgName>
								<address>
									<postCode>I-00040</postCode>
									<settlement>Pomezia Rome</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Stefania</forename><forename type="middle">Di</forename><surname>Marco</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Biochemistry</orgName>
								<orgName type="institution">IRBM P.Angeletti</orgName>
								<address>
									<postCode>I-00040</postCode>
									<settlement>Pomezia Rome</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Andrea</forename><surname>Carfi'</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Biochemistry</orgName>
								<orgName type="institution">IRBM P.Angeletti</orgName>
								<address>
									<postCode>I-00040</postCode>
									<settlement>Pomezia Rome</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Marco</forename><forename type="middle">S</forename><surname>Di</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Biochemistry</orgName>
								<orgName type="institution">IRBM P.Angeletti</orgName>
								<address>
									<postCode>I-00040</postCode>
									<settlement>Pomezia Rome</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Rowley</forename><forename type="middle">M</forename><surname>De</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Biochemistry</orgName>
								<orgName type="institution">IRBM P.Angeletti</orgName>
								<address>
									<postCode>I-00040</postCode>
									<settlement>Pomezia Rome</settlement>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Structural studies of HCV polymerase (genotype 1b) in complex with allosteric inhibitors</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2004-11-25">25 November 2004 to: 26 November 2004</date>
						</imprint>
					</monogr>
					<idno type="MD5">CC6DD028B772CD5654C4A42CA47E32EC</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-05-22T16:00+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">unknown</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=1, consolidateHeader=1, consolidateFunders=0, includeRawAffiliations=false, includeRawCitations=true, includeRawCopyrights=false, generateTeiIds=false, generateTeiCoordinates=[], flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>The hepatitis C virus (HCV) polymerase is required for replication of the viral genome and is a key target for therapeutic intervention against HCV. We have determined the crystal structures of the HCV polymerase complexed with two indole-based allosteric inhibitors at 2.3 A and 2.4 A resolution. The structures show that these inhibitors bind to a site on the surface of the thumb domain. A cyclohexyl and phenyl ring substituents, bridged by an indole moiety, fill two closely spaced pockets whereas a carboxylate substituent forms a salt</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>bridge with an exposed arginine side chain. Interestingly, in the apoenzyme, the inhibitor binding site is occupied by a small alpha-helix at the tip of the N-terminal loop that connects fingers and thumb domains. Thus, these molecules inhibit the enzyme by preventing formation of intramolecular contacts between these two domains and consequently precluding their coordinated movements during RNA synthesis. Our structures identify a novel mechanism by which a new class of allosteric inhibitors inhibits the HCV polymerase and open the way to the development of novel antiviral agents against this clinically relevant human pathogen. Infections caused by hepatitis C virus (HCV) are a significant world health problem for which novel therapies are in urgent demand. Compounds that block replication of subgenomic HCV RNA in liver cells are of interest because of their demonstrated antiviral effect in the clinic. In followup to our recent report that indole-N-acetamides (e.g., 1) are potent allosteric inhibitors of the HCV NS5B polymerase enzyme, we describe here their optimization as cell-based inhibitors. The crystal structure of 1 bound to NS5B was a guide in the design of a two-dimensional compound array that highlighted that formally zwitterionic inhibitors have strong intracellular potency and that pregnane X receptor (PXR) activation (an undesired offtarget activity) is linked to a structural feature of the inhibitor. Optimized analogues devoid of PXR activation (e.g., 55, EC(50) = 127 nM) retain strong cell-based efficacy under high serum conditions and show acceptable pharmacokinetics parameters in rat and dog.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.">J Med</head><p>3. Another paper which includes the structure with other allosteric inhibitors that still bind in the thumb domain of the polymerase is in preparation PDB codes: 2brk and 2brl</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><figDesc>Chem. 2005 Jul 14;48(14):4547-57 Potent Inhibitors of Subgenomic Hepatitis C Virus RNA Replication through Optimization of Indole-N-Acetamide Allosteric Inhibitors of the Viral NS5B Polymerase. Harper S, Avolio S, Pacini B, Di Filippo M, Altamura S, Tomei L, Paonessa G, Di Marco S, Carfi A, Giuliano C, Padron J, Bonelli F, Migliaccio G, De Francesco R, Laufer R, Rowley M, Narjes F. IRBM (Merck Research Laboratories, Rome), Via Pontina km 30,600, 00040 Pomezia, Rome, Italy.</figDesc></figure>
		</body>
		<back>
			<div type="references">

				<listBibl/>
			</div>
		</back>
	</text>
</TEI>
